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Single nucleotide polymorphisms (SNPs) are important markers in many studies that link DNA sequence variations to phenotypic
changes; such studies are expected to advance the understanding of human physiology and elucidate themolecular basis of diseases.
The DFNB1 locus, which contains the GJB2 and GJB6 genes, plays a key role in nonsyndromic hearing loss. Previous studies have
identified important mutations in this locus, but the contribution of SNPs in the genes has not yet been much investigated. The
aim of this study was to investigate the association of nine polymorphisms located within the DFNB1 locus with the occurrence
of autosomal recessive nonsyndromic hearing loss (ARNSHL). The SNPs rs3751385 (C/T), rs7994748 (C/T), rs7329857 (C/T),
rs7987302 (G/A), rs7322538 (G/A), rs9315400 (C/T), rs877098 (C/T), rs945369 (A/C), and rs7333214 (T/G) were genotyped in 122
deaf patients and 132 healthy controls using allele-specific PCR.There were statistically significant differences between patients and
controls, in terms of allelic frequencies in the SNPs rs3751385, rs7994748, rs7329857, rs7987302, rs945369, and rs7333214 (𝑃 < 0.05).
No significant differences between the two groups were observed for rs7322538, rs9315400, and rs877098. Our results suggest that
SNPs present in the GJB2 and GJB6 genes may have an influence on ARNSHL in humans.
1. Introduction
Hearing loss (HL) is a common congenital sensory disorder
worldwide, affecting almost 600 million people. Approxi-
mately 2 to 6 children in 1,000 are affected by severe hearing
loss at birth [1] or during early childhood. This is defined as
prelingual deafness, with about half of cases attributable to
genetic causes. Furthermore, many cases of late onset pro-
gressive HL also have a genetic origin, in addition to pro-
gressive HL associated with ageing [2]. According to the
Hereditary Hearing Loss (HHL) homepage (http://heredi-
taryhearingloss.org/), over 140 loci for nonsyndromic HHL
have been mapped, together with approximately 80 genes,
and more than 1000 mutations have been identified in
humans, making it one of themost genetically heterogeneous
traits. However, in most cases, genetic hearing loss is a
monogenic disorder. Biallelic mutations in 47 different genes
have been reported for autosomal recessive nonsyndromic
hearing loss (ARNSHL),which inmany populations accounts
for 80% of families with this type of deafness [3].
The occurrence of ARNSHL has been related to the
DFNB1 locus (deafness, autosomal recessive 1) (OMIM
220290) at chromosome 13q11-q12, which contains two genes
associated with hearing loss: GJB2 (gap junction protein,
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beta-2) (OMIM 121011) andGJB6 (gap junction protein, beta-
6) (OMIM 604418), which codify the proteins encoding con-
nexins 26 (Cx26) [4] and 30 (Cx30) [5], respectively. Muta-
tions in these genes are the most frequent causes of ARNSHL
inmost populationsworldwide, sometimes accounting for up
to 50% of cases [6].
Direct intercellular communication is mainly mediated
by gap junction channels, which in vertebrates are formed
by members of the connexin protein family. Connexins are
transmembrane proteins that regulate electrical signals and
the passage between neighboring cells of ions, small bio-
logical molecules (<1000Da) including sugars, nucleotides,
and amino acids, secondary messengers such as Ca2+, cyclic
AMP, and inositol triphosphate, and metabolic precursors
[7]. Cochlear gap junctions, especially connexins Cx26 and
Cx30, have been implicated in the maintenance of K+ home-
ostasis in the inner ear [8]. Cx26 and Cx30, the two most
abundantly expressed gap junction proteins in the cochlea,
are coexpressed as heteromeric connexons in nonsensory
cells of the organ of Corti as well as in cells of the spiral
ligament and stria vascularis [9]. Extensive genetic studies
have been conducted to identify mutations in the DFNB1
locus; however, information is lacking concerning the poten-
tial association betweennonsyndromic hearing loss and SNPs
of the GJB2 and GJB6 genes [10].
Single nucleotide polymorphisms (SNPs) are the most
abundant genetic markers at a specific location in the
genome, occurring at a frequency of more than 1% in the
human population [11]. The International HapMap Project
has characterized over 3.1 million human SNPs, indicating a
SNP density of approximately one per kilobase [12]. SNPs are
of great interest in medical and pharmacological studies of
disease susceptibility and drug response. They also provide
powerful tools for a variety of medical genetic studies [13].
In view of all these observations, in an attempt to identify
polymorphisms related to autosomal recessive nonsyndromic
hearing loss, this study investigated the frequency of SNPs
in the GJB2 and GJB6 genes by means of a case-control
association study.
2. Materials and Methods
2.1. Ethics Statement. Written informed consent forms were
obtained from all the participating subjects or from their
parents. The study was approved by the Ethics Commit-
tee at Centro Universita´rio Hermı´nio Ometto de Araras
(UNIARARAS), under protocol number 744/2010.
2.2. Study Subjects. The study involved 122 unrelated new-
born patients of both genders (69 males and 53 females)
with moderate to profound ARNSHL, together with 132
normal controls (CTL). The patients were from the Hearing
and Language Stimulation Therapy Association, in Jundia´ı
(SP, Brazil). This institution is concerned with auditory and
communication disorders, and since 2001 it has developed
a universal hearing screening program. The majority of
subjects studied were classified as Caucasian; however, many
Brazilians have unique mixtures of Amerindian, European,
and African ancestries in their genomic mosaic [14].
Table 1: Summary of selected SNPs.
Gene rs number Position SNP type MAF
GJB2
rs3751385 3󸀠 UTR C/T T = 0.360
rs7994748 Intron C/T C = 0.481
rs7329857 3󸀠 UTR C/T T = 0.079
rs7987302 Downstream G/A A = 0.098
GJB6
rs7322538 Downstream G/A A = 0.214
rs9315400 Intron C/T T = 0.362
rs877098 Intron C/T T = 0.429
rs945369 Intron A/C C = 0.352
rs7333214 3󸀠 UTR T/G T = 0.302
rs number, NCBI reference SNP (rs) number, is an identification tag assigned
by NCBI to SNPs [36]. MAF (ref): minor allele frequency information from
public database, NCBI dbSNP Build 132; MAF ≥ 0.05.
All patients underwent molecular analysis of the coding
region and part of exon 1 and the flanking donor splicing
site of GJB2 and the two deletions affecting the GJB6 gene
(del(GJB6-D13S1830) and del(GJB6-D13S1854)). Also the
1555A>G, 827A>G, and 1494C>T mitochondrial mutations
in the MTRNR1 gene and the 74555A>G mutation in the
MTTS1 gene were analyzed. Following this screening, all
individuals with an identified molecular cause for ARNSHL
were excluded from the study. These previous analyses were
performed at the Center of Molecular Biology and Genetic
Engineering (CBMEG), HumanMolecular Genetics Labora-
tory, State University of Campinas (UNICAMP), Campinas,
SP, Brazil.
The normal controls were recruited from amongst the
employees of UNIARARAS. In order to exclude the influence
of inherited susceptibility factors, information about the
control individuals was collected using questionnaires con-
taining items concerning general health, medical conditions,
and hereditary factors. Subjects with histories of head injury,
otological disease, other diseases that could affect hearing,
and previous or present treatment with ototoxic substances
were excluded.
2.3. SNP Selection. Several SNPs covering the DFNB1
locus were analyzed, seven of these (rs3751385, rs7994748,
rs7329857, rs7987302, rs877098, rs945369, and rs7333214)
were selected from the HapMap database (available at http://
www.hapmap.org/), and SNP genotyping data from the YRI
populationwere downloaded intoHaploview [15]. Only SNPs
that passed quality control criteria (call rate ≥ 95%, minor
allele frequency (MAF) ≥ 0.05, and Hardy-Weinberg disequi-
librium 𝑃 > 0.01) were included in the genetic analysis. Two
other SNPs (rs7322538 and rs9315400) were selected based
on previous reports of association with deafness phenotypes
[10]. Nine SNPs were analyzed, four in theGJB2 gene and five
in theGJB6 gene. A summary of the selected SNPs is provided
in Table 1.
2.4. Genotyping. Genomic DNA was extracted from whole
blood leukocytes using the standard phenol–chloroform
method, as described previously [16]. For genotyping, all
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Table 2: Validation methods for each SNP analyzed.
SNP Gene Method (enzyme)
rs3751385
GJB2
RFLP-PCR (Nhe I)
rs7994748 RFLP-PCR (Bstx I)
rs7329857 RFLP-PCR (Dpn II)
rs7987302 Direct sequencing
rs7322538
GJB6
Direct sequencing
rs9315400 RFLP-PCR (Acu I)
rs877098 RFLP-PCR (Eco RI)
rs945369 RFLP-PCR (Mva I)
rs7333214 RFLP-PCR (Mae II)
the DNA samples were normalized to a concentration of
50 ng/𝜇L.
The SNP genotypes were determined by allele-specific
PCR (AS-PCR) amplification. For analysis of allelic variants,
two forward primers were designed, with the 3󸀠 base of each
primer matching only one of the biallelic SNP bases to be
evaluated. Incorporation of a primer mismatch at the second
or third base from the 3󸀠 end of the primer has been shown
to enhance the specificity of the PCR by further destabilizing
the extension of the doubly mismatched primer [17–19]. A
common reverse primer (COM) was designed downstream
of the polymorphic site. Control primers were also used for
SNP coamplification of a portion of the human amelogenin
(AMELX) gene [20]. These primers were therefore used as
internal amplification controls. The sequences of the primers
used in this study are listed in Table 2.
Approximately 10% of samples, randomly selected, were
regenotyped for cross-validation by restriction fragment
length polymorphism PCR (RFLP-PCR) using restriction
enzyme (New England Biolabs Inc., USA) (see Table 2) or
by direct sequencing of PCR products using ABI BigDye
Terminator, with analysis using an ABI PRISM 3700 DNA
sequencer (Applied Biosystems, Foster City, USA). No incon-
sistencies were observed.
2.5. AS-PCRAmplification and Electrophoresis. ThePCRpro-
cedures were performed using a 30 𝜇L reaction volume con-
taining 50 ng of template DNA, 0.5–0.7 pmol of each forward
and reverse primer, 0.2 pmol of each control primer, 170𝜇M
dNTP, an appropriate concentration of MgCl
2
(Table 3),
0.01% (v/v) BSA, 1X reaction buffer (50mMKCl, 20mMTris-
HCl, pH 8.4), and 1U Taq polymerase (Invitrogen, Itapevi,
SP, Brazil). The samples were incubated at 95∘C for 5min,
followed by 30 cycles of 1min denaturation at 95∘C, 1min
annealing (the times and annealing temperatures for different
PCRs are described in Table 3), 1min extension at 72∘C,
and a final extension at 72∘C for 10min. The amplicons
(Table 3) were separated by electrophoresis in 1.5% agarose
gel stained with ethidium bromide and were visualized and
photographed using the Syngene G:BOX gel documentation
system.
2.6. Statistical Analysis. The Pearson goodness of fit 𝜒2
test was used to assess deviation from Hardy-Weinberg
equilibrium (HWE). Differences in genotype and allele fre-
quencies between the study groups were compared by the
chi-square test and/or Fisher’s exact test. Association between
the SNPs and the risk of autosomal recessive nonsyndromic
hearing loss was analyzed using the binary logistic regression
test. Risk was expressed as odds ratio (OR) with 95%
confidence intervals (CI). An OR > 1.0was used as the cutoff
for the baseline of risk-associated SNPs, and the baseline for
risk-lowering SNPs was OR < 1.0. The Bonferroni post hoc
test was used to comparemultiple groups, using the definition
𝑃 value (single tests) × number of tests. The minor allele
frequency (MAF) for the study was calculated, and a 𝜒2 test
was performed to determine whether there was a significant
difference between the MAF value obtained here and that in
the public MAF database (NCBI dbSNP Build 132). All the
statistical analyses were conducted using GraphPad Prism
5.0 software. A 𝑃 value < 0.05 was taken as statistically
significant.
3. Results
A total of 254 individuals (132 in the control group and 122 in
the patient group) were genotyped for 9 SNPs in the DFNB1
locus, using AS-PCR. Figure 1 shows a representative AS-
PCR gel corresponding to the SNPs rs945369 and rs7333214.
Significant deviations from Hardy-Weinberg equilibrium
were detected in the genotype frequencies of both groups.
HWE 𝑃 values for all the studied SNPs are summarized in
Table 4. Analysis of the results indicated that the minor allele
frequencies of the significant SNPs were in accordance with
the information in the public database, although different
frequencies were found for two of the SNPs, rs7994748
(MAF = 0.173) and rs7987302 (MAF = 0.026) (Table 5).
Out of the nine SNPs included in the study, six (66.7%)
were found to be significantly associated with ARNSHL. Four
of these (rs3751385, rs7994748, rs7329857, and rs7987302)
were found in the GJB2 gene and two (rs945369 and
rs7333214) in the GJB6 gene (Table 6). No significant asso-
ciations were found for the other three SNPs (33.3%) geno-
typed. Three of the four significant SNPs of the GJB2 gene
(rs3751385, rs7994748, and rs7329857) and one SNP of the
GJB6 gene (rs7333214) remained statistically significant after
application of the Bonferroni correction for multiple testing
(×9, 𝑃 values of 1.011× 10−12, 0.036, 3.478 × 10−4, and 0.0027,
resp.). These four SNPs were therefore of sufficient interest to
warrant further investigation. As revealed by the odds ratio
(OR), four of the six SNPs were associated with a high risk
of ARNSHL, with OR > 1, while the remaining two were
associated with a decreased susceptibility to ARNSHL (OR <
1). The rs7329857 SNP of the GJB2 gene was associated with
the highest risk of ARNSHL, with OR of 11.70.
Considering the risk-increasing SNPs, the rs3751385
(C/T) T allele (GJB2 gene) was identified in 90 out of 122
ARNSHL cases (74%), with 40 in heterozygous and 50 in
homozygous genotypes. Likewise, the T allele of rs7994748
(C/T) was present in 92% of the cases (10 in heterozygous and
102 in homozygous genotypes). Other risk-associated SNPs in
the GJB2 gene were only observed to occur in heterozygous
genotypes, and these included 20 cases (16%) for rs7329857
4 BioMed Research International
Table 3: AS-PCR primers and conditions.
Gene
SNP ID
(nucleotide
change)
Sequence (5󸀠-3󸀠)∗ Annealing temperature Mg2+ Amplicon size
GJB2
rs3751385
(C/T)
C allele: GCTCAGCTGTCAAGGCTCAGTCTCC
T allele: GCTCAGCTGTCAAGGCTCAGTCTCT
COM: TTGTCCTCAGAGAAAGAAACAAATGCC
60∘C (1min) 2.5mM 284 bp
rs7994748
(C/T)
C allele: GCTGAGAGCTGGGTTCCGTGTC
T allele: GCTGAGAGCTGGGTTCCGTGTT
COM: AGGGGCTCAGAAGCAGGACG
60∘C (1min) 2.5mM 435 bp
rs7329857
(C/T)
C allele: TTTCCCAACACAAAGATTCTGCC
T allele: TTTCCCAACACAAAGATTCTGCT
COM: CTTACACCAATAACCCCTAACAGCC
58∘C (1min) 2.5mM 199 bp
rs7987302
(G/A)
G allele: GGCATATCAGTCTATGGACAATGGGG
A allele: GGCATATCAGTCTATGGACAATGGGA
COM: AGAGGTTGCAGTGAGCCAAGG
58∘C (1min) 1.7mM 157 bp
GJB6
rs7322538
(G/A)
G allele: CTAATGCAACTAGGGAAATTCG
A allele: CTAATGCAACTAGGGAAATTCA
COM: GCAATCTAGTTTTTCCTCATCC
56∘C (45 s) 2.2mM 106 bp
rs9315400
(C/T)
C allele: GCAGCCTAGCATTTTACATC
T allele: GCAGCCTAGCATTTTACATT
COM: GTCTCTTTTTCGCAACCTTG
55∘C (45 s) 2.5mM 100 bp
rs877098
(C/T)
C allele: AAGGGAGCTTGGAAATGAAGTC
T allele: AAGGGAGCTTGGAAATGAAGTT
COM: GAGGTGGAGCTTGCAGTGAG
56∘C (1min) 2.5mM 227 bp
rs945369
(A/C)
A allele: GTCCCTGTTTTTAGAAAAAAAGAA
C allele: GTCCCTGTTTTTAGAAAAAAAGAC
COM: GGAAGTAAACAGATCAGGGAG
59∘C (1min) 2.5mM 187 bp
rs7333214
(T/G)
T allele: AACATTTATCCAGGAATTGATATT
G allele: AACATTTATCCAGGAATTGATATG
COM: CAAATTTGCCAACAGACAATGC
57∘C (1min) 2.5mM 230 bp
Controls primers
AMELX CTLA: CCCACCTTCCCCTCTCTCCAGGCAAATGGG
CTLB: GGGCCTCAGTCCCAACATGGCTAAGAGGTG
360 bp
COM: commonprimer (reverse).∗Themismatches of the allele-specific primers are underlined. SNP ID: identification of the SNP.AMELX: human amelogenin
gene used as an internal amplification control.
Table 4: Hardy-Weinberg proportions in the groups studied.
Gene SNP HWE P value (CTL) HWE 𝑃 value (patients)
GJB2
rs3751385 0.143 0.001
rs7994748 0.711 6.692 × 10−11
rs7329857 0.994 0.615
rs7987302 0.917 0.895
GJB6
rs7322538 0.740 0.435
rs9315400 0.653 0.557
rs877098 4.312 × 10−18 3.221 × 10−27
rs945369 0.0082 0.003
rs7333214 0.995 0.156
HWE: Hardy-Weinberg equilibrium test was done using Pearson’s goodness
of fit 𝜒2 test and 𝑃 value <0.05 was considered to show significant deviation
of the observed genotypes from Hardy-Weinberg proportions. Significant
deviations values from Hardy-Weinberg equilibrium are shown in boldface.
(C/T) and 10 cases (8%) for rs7987302 (G/A). The presence
of rs945369 (A/C) in the GJB6 gene was observed to be
associated with decreased risk of ARNSHL, with 38 of the
patients heterozygous (31%) and 23 of the cases (19%) CC
homozygous. A genetic association of SNP rs7333214 (T/G)
with ARNSHL was identified in 94% of the patients, with 61
heterozygous and 54 GG homozygous genotypes. The results
of the association analysis are summarized in Table 6.
4. Discussion
Genome-wide association studies (GWAS) have successfully
identified numerous loci that influence disease risk. Such
techniques have been proved to offer powerful approaches
for the screening of genes involved in complex diseases [21],
including hearing loss, which occurs in around one per 1,000
newborns on average [22].
The current study evaluated the relationships between
polymorphisms in the GJB2 and GJB6 genes and autoso-
mal recessive nonsyndromic hearing loss in a sample of
the Brazilian population. Evidence was found that SNPs
in both genes were significantly associated with ARNSHL.
Data for 122 patients and 132 controls indicated that GJB2
BioMed Research International 5
Table 5: Comparative analysis betweenminor allele frequency described in the database andminor allele frequency in the whole study group.
Gene SNP ID (nucleotide change) MAF ref MAF study 𝑃 value (ref × study)
GJB2
rs3751385 (C/T) T = 0.360 0.405 0.513
rs7994748 C/T C = 0.481 0.173 3.442 × 10−6
rs7329857 C/T T = 0.079 0.043 0.287
rs7987302 G/A A = 0.098 0.026 0.035
GJB6
rs7322538 G/A A = 0.214 0.114 0.056
rs9315400 C/T T = 0.362 0.451 0.200
rs877098 C/T T = 0.429 0.486 0.418
rs945369 A/C C = 0.352 0.400 0.472
rs7333214 T/G T = 0.302 0.236 0.293
MAF (ref) ≥0.05: minor allele frequency information from public database, NCBI dbSNP Build 132; MAF (study): minor allele frequency in the whole study
group. Significant values are shown in boldface.
AA AC CC
Control primers 360bp
Control primers 360bp
A allele 187 bp
C allele 187 bp
(a)
Control primers 360bp
Control primers 360bp
T allele 230bp
G allele 230bp
TT TG GG
(b)
Figure 1: Electrophoretic patterns observed on AS-PCR analysis of the SNPs rs945369 (a) and rs7333214 (b). DNA ladder molecular weight
marker (100 bp) was run in the first lane as labeled.The photo shows all three genotypes obtained from study individuals seen on the ethidium
bromide-stained 1.5% agarose gel. AA: homozygote for the allele A; AC: heterozygote for the alleles A and C; CC: homozygote for the allele
C (a). TT: homozygote for the allele T; TG: heterozygote for the alleles T and G; GG: homozygote for the allele G (b).
rs3751385 (C/T) was associated with hearing loss suscep-
tibility, in agreement with previously published research
[21, 23, 24].
The T allele of this SNP (rs3751385) has also been
shown to be a risk factor associated with chronic plaque
psoriasis in Chinese Han population patients [25]. A similar
finding was reported for Chinese patients with psoriatic
arthritis [26], possibly because connexin 26 (Cx26) has been
found to be highly expressed in psoriasis plaques. Cx26
is widely expressed in most human tissues, including the
ectoderm-derived epithelia of the cochlea, cornea, and skin
[27].
Wilch et al. [28] previously showed that the expression of
GJB2 and GJB6 diminished in the presence of the rs7333214
G allele. Conversely, in this study, the presence of the T allele
was found to be positively associated with ARNSHL.
Here, to the best of our knowledge, we describe for the
first time the association between the rs7994748, rs7329857,
rs7987302, and rs945369 SNPs and ARNSHL. The results
indicate that these genetic changes may be important deter-
minants of hearing impairment risk in the studied popula-
tion. The rs7994748 and rs945369 SNPs are present in the
intronic regions of the GJB2 and GJB6 genes, respectively.
It has been shown previously that SNPs present in the
noncoding region can modulate gene expression [29]. The
rs3751385 and rs7329857 SNPs are located in the 3󸀠UTR
region of the GJB2 gene, while rs7333214 is found in the
GJB6 gene. The 3󸀠UTR region of a gene is usually impor-
tant for regulation of processes such as transcript cleavage,
alternative polyadenylation, and mRNA nuclear export [30].
Mutations in 3󸀠UTR of certain genes have been reported to
be associated with several genetic diseases [31–33]. Recently,
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Ramsebner et al. [34] showed that the rs117685390 C allele in
the regulatory region of the human GJB2 gene could contrib-
ute to autosomal recessive nonsyndromic hearing loss.
Our study showed no significant differences between
control and hearing loss subjects in terms of the distribution
of alleles of the rs7322538, rs9315400, and rs877098 SNPs
in the GJB6 gene. Similarly, no significant differences were
detected between noise-induced hearing loss (NIHL) and
normal groups when Abreu-Silva and colleagues [35] com-
pared allele and genotype frequencies for the rs877098 SNP.
Elsewhere, negative associations of rs7322538 with sporadic
hearing impairment were found in the Chinese population
[10]. The same study showed a significant difference in allele
frequency for rs9315400, most likely due to the different
ethnicity.
5. Conclusions
The present findings indicate that the rs7322538, rs9315400,
and rs877098 SNPs in the GJB6 gene are not a significant
risk factor for the development of ARNSHL in the Brazilian
population. However, in contrast to these SNPs, it was found
that carriers of the T allele of the SNPs rs3751385 (C/T),
rs7994748 (C/T), rs7329857 (C/T), and rs7333214 (T/G) are
at increased risk of ARNSHL.
Further studies are required to confirm these findings and
to explore the hypothesis that the rs7994748 T, rs7329857
T, rs7987302 A, and rs945369 A alleles could be used as
biomarkers for the development of autosomal recessive non-
syndromic hearing loss in Brazilian populations and could be
included in assessments of the risk of developing ARNSHL.
Finally, we provide important evidence of the association
of SNPs in the GJB2 and GJB6 genes with hearing loss.
The findings of this study contribute to an understanding of
the intricate associations and gene interactions involved in
hereditary hearing loss.
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